Form 4: Elanco Executive Acquires Deferred Stock Units

Rajeev A. Modi, Elanco's EVP, acquired 78.9849 deferred stock units, increasing his beneficial ownership to 6,814.29 units.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc., acquired 78.9849 Deferred Stock Units (DSUs).
• Each DSU represents the right to receive one share of Elanco common stock or its cash equivalent.
• The DSUs were acquired on August 22, 2025, at a price of $17.91 per unit.
• Following this transaction, Modi beneficially owns a total of 6,814.29 DSUs.
• These units will settle in cash or shares upon termination of employment or a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by an executive is generally a positive signal, indicating alignment of interests and confidence in the company's future. It's a routine compensation event, not a major market-moving transaction, hence a moderately positive score.

Positives

• An executive is increasing their beneficial ownership in the company, which can signal confidence in future performance.
• The acquisition of deferred stock units aligns executive incentives with long-term shareholder value.

Future Outlook

The deferred stock units are designed to settle in cash or shares of company common stock following termination of employment or during a specified future year, aligning executive incentives with long-term company performance.

Management Comments

• Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
• Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

This transaction is a routine insider filing, common in the animal health industry and other sectors, where executive compensation often includes equity-based incentives like deferred stock units to align management interests with shareholder value over the long term.

Comparison to Industry Standards

• The use of Deferred Stock Units (DSUs) as part of executive compensation is a standard practice across many industries, including the pharmaceutical and animal health sectors, for companies like Zoetis Inc. (ZTS) or IDEXX Laboratories, Inc. (IDXX).
• The structure, where DSUs convert to common stock or cash upon specific events (e.g., termination or future date), is typical for long-term incentive plans aimed at executive retention and performance alignment.

Stakeholder Impact

• Shareholders: The transaction aligns executive incentives with long-term shareholder value, potentially fostering better performance.
• Employees: No direct impact on general employees, but it reflects the company's executive compensation strategy.

Next Steps

• The deferred stock units will settle in cash or shares of Elanco common stock upon termination of employment or during a specified future year.

Key Dates

Recommendation

This Form 4 filing reports a routine acquisition of deferred stock units by an executive as part of their compensation package. While it indicates management's continued alignment with the company's long-term performance, it does not present new fundamental information that would warrant a change in investment thesis. It's a standard insider transaction, not a significant open-market purchase or sale that would signal a strong 'buy' or 'sell' opportunity.

Keywords

Elanco Animal Health, ELAN, Rajeev A. Modi, Deferred Stock Units, DSU, Insider Transaction, Executive Compensation, Stock Ownership